Entresto 49 MG-51 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJ4YA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $198,545
Award facts
- Contract value 100% obligated
- $198,544.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count units) with a ceiling value of $198,544.50 under a firm fixed-price arrangement. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency and broader military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills critical medical procurement needs for federal defense and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's substantial indefinite delivery contract with DLA Troop Support Medical demonstrates its established capability to meet federal pharmaceutical supply requirements across multiple therapeutic domains, enabling it to deliver specialized medications and medical commodities to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FJ4YA?
SPE2DB25FJ4YA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FJ4YA worth?
The government has obligated $198,545 on SPE2DB25FJ4YA.
Is contract SPE2DB25FJ4YA an order under another contract?
Yes. SPE2DB25FJ4YA is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ4YA competed?
The extent of competition for SPE2DB25FJ4YA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award